High blood pressure medications rarely have names that roll gracefully off the tongue, and angiotensin II receptor blockers are no exception. Fortunately, doctors usually shorten the name to ARBs, saving everyone several syllables and at least one deep breath.
ARBs are prescription medications commonly used to treat high blood pressure. Depending on the specific drug and the patient’s medical history, they may also help manage heart failure, protect the kidneys, reduce protein in the urine, or lower the risk of certain cardiovascular complications.
These medications are generally well tolerated, especially by people who develop a persistent cough while taking an angiotensin-converting enzyme inhibitor, better known as an ACE inhibitor. However, “generally well tolerated” does not mean “take one and forget about it forever.” ARBs can affect blood pressure, kidney function, and potassium levels, so appropriate monitoring matters.
This guide explains how ARBs work, their potential benefits, common and serious risks, medication interactions, and the practical details patients should understand before and during treatment.
What Are Angiotensin II Receptor Blockers?
Angiotensin II receptor blockers are medications that interfere with the body’s renin-angiotensin-aldosterone system, or RAAS. This hormone system helps regulate blood pressure, blood volume, sodium balance, and kidney function.
Angiotensin II normally causes blood vessels to tighten. It also encourages the release of aldosterone, a hormone that tells the kidneys to retain sodium and water. Narrower blood vessels plus extra fluid can raise blood pressure and increase the workload placed on the heart.
ARBs block angiotensin II from attaching to its primary receptors, known as AT1 receptors. With that signal interrupted, blood vessels remain more relaxed, blood pressure decreases, and the heart can pump against less resistance. ARBs may also reduce pressure inside the kidneys’ filtering structures, which helps explain their role in treating certain forms of chronic kidney disease.
Common ARB medications
Frequently prescribed ARBs in the United States include:
- Azilsartan
- Candesartan
- Irbesartan
- Losartan
- Olmesartan
- Telmisartan
- Valsartan
Many are available as generic medications. ARBs may also be combined in a single tablet with another blood pressure medicine, such as a thiazide diuretic or calcium channel blocker. The best choice depends on the condition being treated, kidney and liver function, other medications, cost, and how the individual responds.
What Conditions Do ARBs Treat?
High blood pressure
Hypertension is the most common reason an ARB is prescribed. By relaxing blood vessels, ARBs reduce resistance to blood flow and lower blood pressure throughout the circulatory system.
Managing high blood pressure is important even when a person feels perfectly healthy. Hypertension often causes no obvious symptoms while quietly increasing the risk of stroke, heart attack, heart failure, kidney damage, and other complications. ARBs may be used alone, but many patients need two or more types of blood pressure medicine to reach their treatment target.
Chronic kidney disease and albuminuria
ARBs are especially valuable for some people who have chronic kidney disease accompanied by albuminuria, meaning excess albumin is leaking into the urine. Albumin is a protein that normally remains in the bloodstream. When it appears in urine, it can be a sign that the kidneys’ filters are under strain or have been damaged.
By reducing pressure within these filters, an ARB may lower urine albumin levels and slow the progression of kidney disease. These benefits can be relevant to people with diabetes, hypertension, or other conditions involving protein loss in the urine. Kidney protection does not mean ARBs are harmless to the kidneys, however. Kidney function still needs to be checked, particularly after treatment begins or the dose changes.
Heart failure
Certain ARBs may be used in heart failure to widen blood vessels, lower blood pressure, and reduce the workload on the heart. They are often considered when an ACE inhibitor is not tolerated or when another recommended form of renin-angiotensin system treatment is unsuitable.
Modern heart failure treatment frequently involves several medication classes working together. In some patients with heart failure with reduced ejection fraction, an angiotensin receptor-neprilysin inhibitor, or ARNI, may be preferred. One widely used ARNI contains valsartan, but it is not simply a regular valsartan tablet with a fancy name tag; it is a combination medicine with different prescribing considerations.
Other cardiovascular and kidney-related uses
Specific ARBs have additional approved uses. Losartan, for example, may be prescribed to reduce stroke risk in certain people who have hypertension and left ventricular hypertrophy. It is also used for diabetic nephropathy in appropriate patients with type 2 diabetes and hypertension. Valsartan may be used following a heart attack or as part of heart failure treatment.
Not every ARB is approved for every ARB-related condition. Patients should not assume that medications ending in “-sartan” are interchangeable without medical guidance.
Major Benefits of ARBs
Effective blood pressure reduction
ARBs can provide steady blood pressure control with once-daily dosing in many patients. Lowering blood pressure reduces long-term stress on the arteries, heart, brain, and kidneys. Their effectiveness also makes them useful in combination therapy when one medication is not enough.
Less cough than ACE inhibitors
ACE inhibitors and ARBs affect the same broad hormone system, but they intervene at different points. ACE inhibitors reduce the production of angiotensin II and can increase bradykinin, a substance associated with the familiar ACE inhibitor dry cough.
ARBs block angiotensin II receptors without producing the same degree of bradykinin accumulation. As a result, coughing is much less common. This is one reason a clinician may switch a patient from an ACE inhibitor to an ARB. Real-world comparative research has found similar cardiovascular effectiveness for people beginning hypertension treatment, while ARBs were associated with fewer medication-related side effects.
Heart and kidney protection in selected patients
The value of ARBs extends beyond the number displayed on a blood pressure monitor. For appropriate patients, they may reduce albuminuria, slow kidney disease progression, and decrease strain on a weakened heart.
These benefits depend on the diagnosis, dose, adherence, and whether the medication can be continued safely. An ARB does not cancel out smoking, excessive sodium intake, uncontrolled diabetes, inactivity, or missed appointments. Sadly, no blood pressure tablet has yet received FDA approval for doing a patient’s morning walk on their behalf.
Common ARB Side Effects
Many people take ARBs without significant problems. When side effects occur, they may include:
- Dizziness or lightheadedness
- Fatigue
- Headache
- Low blood pressure
- Nausea or digestive discomfort
- Changes in kidney function
- Elevated blood potassium
Dizziness is more likely when treatment begins, after a dose increase, or when the patient is dehydrated. Standing up slowly can help reduce lightheadedness, but persistent dizziness, fainting, or unusually low home blood pressure readings should be reported to a healthcare professional.
Side effects can also come from medications combined with an ARB. For example, a tablet containing an ARB and a diuretic may cause additional urination, dehydration, sodium changes, or gout-related problems attributable to the diuretic component.
Important Risks and Warnings
High potassium levels
ARBs can reduce the amount of potassium eliminated by the kidneys, sometimes causing hyperkalemia. Mild hyperkalemia may cause no symptoms. Severe elevations can interfere with the heart’s electrical activity and become dangerous.
Risk is higher in people with chronic kidney disease, diabetes, dehydration, or existing high potassium. It also increases when ARBs are combined with potassium supplements, potassium-containing salt substitutes, or medicines that raise potassium, including spironolactone, eplerenone, amiloride, and certain other therapies.
Kidney function changes
A modest change in kidney filtration markers may occur after an ARB is started because the medicine changes pressure inside the kidneys. Clinicians interpret this change in context rather than reacting to a single laboratory number.
Larger or progressive changes can signal a problem, especially in patients who are dehydrated, taking nonsteroidal anti-inflammatory drugs, or living with narrowing of the arteries supplying the kidneys. This is why serum creatinine, estimated glomerular filtration rate, and potassium are commonly checked before and after starting therapy.
Low blood pressure
Excessive blood pressure reduction may cause weakness, blurred vision, confusion, dizziness, or fainting. The risk can rise when an ARB is combined with diuretics, other blood pressure medicines, significant fluid loss, or a very low-sodium diet.
Pregnancy-related fetal harm
ARBs carry a boxed warning because medications that act directly on the renin-angiotensin system can seriously harm a developing fetus. Exposure later in pregnancy can reduce fetal kidney function and cause low amniotic fluid, lung and skeletal complications, kidney failure, or death.
A person who becomes pregnant while taking an ARB should contact the prescribing clinician promptly. Those planning a pregnancy should discuss alternative blood pressure treatments in advance rather than waiting for a positive test to begin the conversation.
Angioedema and allergic reactions
Angioedema is uncommon with ARBs but can occur. Symptoms may include swelling of the lips, tongue, face, or throat, sometimes accompanied by difficulty breathing or swallowing. This requires emergency medical attention.
Severe diarrhea linked to olmesartan
Olmesartan has been associated with a rare intestinal condition called sprue-like enteropathy. It may cause severe, persistent diarrhea and substantial weight loss, sometimes months or years after treatment begins. Patients taking olmesartan should report unexplained chronic diarrhea rather than assuming their digestive system has simply developed a dramatic personality.
ARB Drug and Supplement Interactions
Before taking an ARB, patients should provide their clinician or pharmacist with a complete list of prescriptions, over-the-counter medicines, supplements, and salt substitutes.
NSAID pain relievers
Nonsteroidal anti-inflammatory drugs, or NSAIDs, include ibuprofen and naproxen. Regular or high-dose use may reduce an ARB’s blood pressure-lowering effect and increase the risk of kidney injury, particularly in older adults, dehydrated patients, and people who also take a diuretic.
Potassium-containing products
Potassium supplements and potassium-based salt substitutes can raise potassium further. Patients should not assume that a product is safe merely because the label includes words such as “natural,” “electrolyte,” or “heart healthy.”
Lithium
ARBs may increase lithium concentrations and the risk of lithium toxicity. Patients taking lithium may require closer laboratory monitoring or an alternative medication plan.
Other renin-angiotensin system medicines
Taking an ARB together with an ACE inhibitor is generally avoided because dual blockade raises the risk of low blood pressure, hyperkalemia, and impaired kidney function without providing enough added benefit for most patients. Similar concerns may apply to combinations involving the direct renin inhibitor aliskiren.
Patients taking an ARNI should remember that the medicine already contains an ARB component. Adding a separate ARB could unintentionally duplicate therapy.
ARBs vs. ACE Inhibitors
ACE inhibitors and ARBs both help relax blood vessels and are used for overlapping conditions. Neither group is automatically better for every patient.
An ACE inhibitor may be selected because it has strong evidence for a particular diagnosis, is familiar to the prescribing clinician, or is affordable and effective for the patient. An ARB may be favored when an ACE inhibitor causes a persistent cough or is otherwise poorly tolerated.
ARBs are less likely to cause cough and may have a lower risk of angioedema, but that risk is not zero. Both classes can raise potassium, lower blood pressure, affect kidney function, and harm a developing fetus. They should generally not be taken together.
Monitoring While Taking an ARB
Safe ARB treatment usually includes a combination of home observations and clinical monitoring.
Blood pressure checks
Home readings can show whether the medication is working outside the clinic. For more consistent results, patients should sit quietly, support the arm, use a properly sized cuff, and take readings under similar conditions. A short log showing dates, times, readings, symptoms, and missed doses can be more useful than one heroic measurement taken immediately after climbing the stairs.
Kidney function and potassium tests
Clinicians commonly check creatinine or estimated glomerular filtration rate and potassium before starting an ARB. Testing is often repeated within approximately one to two weeks after initiation or a dose adjustment, although timing may vary according to kidney function, age, other medicines, and overall risk. Stable patients may need periodic monitoring afterward.
Medication and lifestyle review
Follow-up appointments are also an opportunity to review NSAID use, supplements, hydration, sodium intake, alcohol consumption, and adherence. A medication cannot provide consistent protection when doses disappear on weekends, vacations, or days ending in the letter “y.”
Practical Experiences Patients Commonly Encounter With ARBs
The following scenarios reflect common treatment experiences rather than personal medical testimony. Individual responses vary, and medication decisions should always be made with a qualified healthcare professional.
The first-week dizziness experience
A patient starts an ARB on Monday and feels slightly lightheaded on Tuesday morning. The immediate reaction may be, “This medicine hates me.” In reality, the body may simply be adjusting to a lower pressure, especially if the patient was also taking a diuretic or was mildly dehydrated.
A practical response is to measure blood pressure, stand up slowly, stay appropriately hydrated, and contact the clinician if symptoms are severe or persistent. Fainting, confusion, chest pain, or significant weakness should not be treated as a routine adjustment period.
The surprisingly boring success story
Another person begins losartan and notices absolutely nothing. No burst of energy, no warm glow, no triumphant soundtrack. Their home readings simply decline over several weeks.
This quiet response is often what successful hypertension treatment looks like. High blood pressure may not cause noticeable symptoms, and lowering it may not create an obvious physical sensation. The benefit is frequently preventive: less long-term damage to blood vessels and vital organs.
Switching after an ACE inhibitor cough
A patient takes an ACE inhibitor and develops a persistent dry cough. It is not dangerous, but it is annoying enough to turn every quiet room into an involuntary solo performance. After evaluation, the clinician changes the prescription to an ARB.
The cough may gradually resolve because ARBs do not influence bradykinin in the same way. However, patients should not switch medicines independently. A cough can also result from asthma, reflux, infection, heart failure, smoking, or other causes that deserve attention.
The potassium surprise
A patient feels fine at a follow-up visit but laboratory testing shows elevated potassium. This experience demonstrates why symptom-free monitoring matters. Electrolyte changes do not always announce themselves.
The clinician may review kidney function, diet, supplements, salt substitutes, and other prescriptions. Perhaps the patient has been using a potassium-based seasoning, taking a supplement, and eating multiple high-potassium foods while also using spironolactone. None of those choices is automatically wrong, but together they may require adjustment.
The dehydration and pain-reliever problem
Consider someone taking an ARB and a diuretic who develops vomiting and diarrhea. They become dehydrated and take ibuprofen for body aches. That combination can place additional stress on the kidneys.
Patients should ask their healthcare team in advance what to do during illnesses that cause substantial fluid loss. They should not invent a universal “sick-day rule” or permanently discontinue treatment, but early professional advice can prevent a temporary illness from becoming a medication-related kidney problem.
The home blood pressure detective
Some patients become so enthusiastic about monitoring that they check their blood pressure 18 times before breakfast. That can create anxiety and produce a pile of readings with little practical value.
A better experience usually comes from following a consistent schedule recommended by the clinician. Two properly taken readings in the morning and evening for a limited period may reveal more than random measurements taken after coffee, exercise, an argument, or an especially exciting football game.
The adherence reality check
ARBs work best when taken consistently. Missed doses can create fluctuating blood pressure and make it difficult to determine whether the prescription is effective.
Patients often improve adherence by linking the dose to a daily routine, using a pill organizer, setting a reminder, or requesting a 90-day supply when appropriate. Anyone who misses a dose should follow the instructions supplied with the prescription or ask a pharmacist rather than doubling the next dose automatically.
These experiences share one central lesson: good ARB treatment is not simply about swallowing a tablet. It is a partnership involving realistic routines, home blood pressure data, laboratory monitoring, and honest communication about side effects, supplements, illnesses, and missed doses.
When to Contact a Healthcare Professional
Patients should contact their healthcare team promptly for persistent dizziness, fainting, unusually low blood pressure, reduced urination, worsening swelling, muscle weakness, irregular heartbeat sensations, severe diarrhea, significant vomiting, or suspected pregnancy.
Emergency care is appropriate for swelling of the face, tongue, lips, or throat; difficulty breathing; severe confusion; collapse; chest pain; or other symptoms suggesting a serious allergic, cardiovascular, or electrolyte-related reaction.
Conclusion
Angiotensin II receptor blockers are important medications for managing high blood pressure and selected heart or kidney conditions. They lower blood pressure by blocking the effects of angiotensin II, allowing blood vessels to relax and reducing strain on the cardiovascular system.
ARBs are often easier to tolerate than ACE inhibitors because they are less likely to cause a dry cough. Their potential benefits may include dependable blood pressure control, reduced albuminuria, slower kidney disease progression, and support for certain patients with heart failure.
The main safety concerns include dizziness, low blood pressure, elevated potassium, changes in kidney function, medication interactions, and serious fetal harm during pregnancy. Regular blood pressure checks, kidney function testing, potassium monitoring, and medication reviews help clinicians balance these risks against the expected benefits.
Medical note: This article provides general educational information and is not a substitute for diagnosis, individualized treatment, or advice from a physician, pharmacist, or other licensed healthcare professional. Do not start, stop, combine, or change the dose of an ARB without appropriate medical guidance.
